진료과/의료진

본문 바로가기 글로벌 네비게이션 바로가기

검색어 입력

의료진 소개

호흡기·알레르기내과
이승현 교수

관심의료진

전문분야

폐암, 간질성폐질환, 만성기도질환, 검진 결과상담

진료일정

진료과 센터 암병원

의료진 시간표 상세 내용 제공
오전	월요일 오전 암병원 진료 가능	화요일 오전 암병원 진료 가능				토요일 오전 진료과 진료 가능
오후			수요일 오후 진료과 진료 가능	목요일 오후 진료과 진료 가능

진료예약

직위

직위 정보 제공
병원	교수

학력

학력 정보 제공
2006 ~ 2012	고려대대학원 내과학과 박사

경력 및 연수

경력 및 연수 정보 제공
2023 ~ 현재	경희대학교병원 제8중환자실(내과계) 실장
~ 현재	경희대학교병원 QI 3차장
2020 ~ 현재	경희대학교병원 호흡기알레르기내과 부교수
~	경희대학교병원 호흡기내과 진료과장
2016 ~ 2020	경희대학교병원 호흡기알레르기내과 조교수
2013 ~ 2016	한전의료재단 한전병원 호흡기내과 과장
2012 ~ 2013	고대안암병원 호흡기내과 임상조교수
2010 ~ 2012	고대안암병원 호흡기내과 임상강사

학회활동

학회활동 정보 제공
2021 ~ 현재	대한 폐암학회 평의원
2021 ~ 현재	European Society for Medical Oncology (ESMO) member
2020 ~ 현재	Asian Pacific Society of Respirology (APSR) member
2020 ~ 현재	대한 결핵 및 호흡기학회 기획위원
2019 ~ 현재	대한 내과학회 교육위원
2016 ~ 현재	International Association for the Study of Lung Cancer (IASLC) Member

저서

저서 정보 제공
2016.11	호흡기학 Manual
2020.08	호흡기학 manual : 호흡기내과 전공의를 위한 실용적인 치료 지침서

수상이력

수상이력 정보 제공
2021	고의의학상
2021	KALC International Conference Best Presentation Award
2018	대한결핵 및 호흡기학회 우수초록상
2018	대한폐암학회 학술상

논문

논문 정보 제공
2022.	Capmatinib in MET Exon 14 Skipping Mutation-Positive Lung Adenocarcinoma with Extensive Central Nervous System Metastasis
2022.	High Tumor Mutation Burden Is Associated with Poor Clinical Outcome in EGFR-Mutated Lung Adenocarcinomas Treated with Targeted Therapy
2022.	A Study on the Perception of Concurrent Use of Western and Korean Medicine Care and Integrated Medical Service in Korea - Targeting tertiary hospital users
2022.	Tyrosine Kinase Inhibitor Activity in Patients with NSCLC Harboring Uncommon EGFR Mutations: A Retrospective International Cohort Study (UpSwinG)
2021.	Overexpression of Reactive Oxygen Species Modulator 1 Predicts Unfavorable Clinical Outcome in EGFR-Mutant Lung Adenocarcinomas Treated With Targeted Therapy
2021.	Metataxonomic investigation of the microbial community in the trachea and oropharynx of healthy controls and diabetic patients using endotracheal tubes
2021.	Serum Reactive Oxygen Species Modulator 1 as a Novel Predictive Biomarker for Resected Lung Adenocarcinoma: A Retrospective Pilot Study
2021.	Sequential afatinib and osimertinib in patients with EGFR mutation-positive NSCLC and acquired T790M: A global non-interventional study (UpSwinG)
2021.	Angiogenic activities are increased via upregulation of HIF-1α expression in gefitinib-resistant non- small cell lung carcinoma cells
2021.	Detection of intracellular lamellar bodies as a screening marker for fibrotic lesions
2021.	Repeated intratracheal instillation of zinc oxide nanoparticles induced pulmonary damage and a systemic inflammatory response in cynomolgus monkeys
2021.	Treatment outcomes and safety of afatinib in advanced squamous cell lung cancer progressed after platinum-based doublet chemotherapy and immunotherapy (SPACE study)
2021.	Effectiveness and safety of herbal medicine for cancer-related fatigue in lung cancer survivors: A systematic review and meta- analysis
2020.	Coexisting active pulmonary tuberculosis in tuberculous spondylitis: the prevalence and the role of chest CT
2020.	KCP10043F Represses the Proliferation of Human Non-Small Cell Lung Cancer Cells by Caspase- Mediated Apoptosis via STAT3 Inactivation
2020.	The Efficacy and Safety of Acupuncture for Preventing Radiation Pneumonitis in Patients With Lung Cancer: A Prospective, Single-Blinded, Randomized Pilot Proof-of-Principle Study
2020.	Evaluating the effect of a smartphone app-based self- management program for people with COPD: A randomized controlled trial
2020.	Primary Resistance to Immune Checkpoint Blockade in an STK11/TP53/KRAS- Mutant Lung Adenocarcinoma with High PD-L1 Expression
2020.	Reactive Oxygen Species Modulator 1 is Associated with Poor Survival in Patients with Non-Small Cell Lung Cancer After Stereotactic Fractionated Radiosurgery: A Retrospective Pilot Study
2020.	High PD-L1 Expression is Associated with Unfavorable Clinical Outcome in EGFR-Mutated Lung Adenocarcinomas Treated with Targeted Therapy
2020.	Diagnostic and Predictive Values of 18 F-FDG PET/CT Metabolic Parameters in EGFR-Mutated Advanced Lung Adenocarcinoma
2020.	Formation of lamellar body-like structure may be an initiator of didecyldimethylammonium chloride-induced toxic response
2020.	The efficacy and safety of Kyung- Ok-Ko on cancer-related fatigue in lung cancer patients: Study protocol for a randomized, patients-assessor blind, placebo-controlled, parallel- group, single-center trial.
2020.	Radiosensitizing effect of combined triptolide and irradiation treatment in lung cancer cell lines
2019.	Reactive Oxygen Species Modulator 1 As An Adverse Prognostic Marker In Stage III Non-Small Cell Lung Cancer Treated With Radiotherapy: A Retrospective Pilot Study
2019.	Clinical utility of a novel natural killer cell activity assay for diagnosing non-small cell lung cancer: a prospective pilot study
2019.	Hyaluronic acid-induced diffuse alveolar hemorrhage: unknown complication induced by a well- known injectable agent
2019.	Impact of Pulmonary Tuberculosis on the EGFR Mutational Status and Clinical Outcome in Patients with Lung Adenocarcinoma
2019.	Comparison of T790M Acquisition Between Patients Treated with Afatinib and Gefitinib as First-Line Therapy: Retrospective Propensity Score Matching Analysis

학술활동

학술활동 정보 제공
NANOG predicts poor outcome in advanced non-small cell lung cancer patients treated with platinum-based chemotherapy
Reactive Oxygen Species Modulator 1 (Romo1) Predicts Poor Outcomes in Advanced Non-Small Cell Lung Cancer Patients Treated with Platinum-Based Chemotherapy
Reactive oxygen species modulator 1 (Romo1) as a diagnostic marker for lung cancer-related malignant effusion
NANOG predicts poor outcome in advanced non-small cell lung cancer patients treated with platinum-based chemotherapy
Prognostic value of plasma soluble ST2 concentration in respiratory failure patients
Deep vein thrombosis, pulmonary thromboembolism, aortic valve vegetation, and stroke in a patient with advanced lung adenocarcinoma: A case of Trousseau’s syndrome
Pemetrexed continuation maintenance versus conventional platinum-based doublet chemotherapy in EGFR-negative lung adenocarcinoma: retrospective analysis
Clinical manifestations of subjects with COPD depending on comorbid depression and risk factors associated with depression
A case of diffuse alveolar hemorrhage after illegal vaginal injection of hyaluronic acid
TAS-116, a novel heat shock protein 90 inhibitor, enhances radiosensitivity of non-small cell lung cancer cells
A case of pulmonary capillary hemangiomatosis presented as recurrent pneumothorax
Triptolide potentiates pemetrexed-induced lung cancer cell death via heat shock protein 70 inhibition
Pemetrexed continuation maintenance versus conventional platinum-based doublet chemotherapy in EGFR-negative lung adenocarcinoma: retrospective analysis
A case of AL amyloidosis mimicking lymphoproliferative disease
재발성 기흉으로 내원하여 진단된 Birt-Hogg-Dub? 증후군 1예
EGFR 돌연변이 양성 폐선암에서 아파티닙 치료 후 편평세포암으로의 조직형 변환 및 T790M 돌연변이가 동시 발견된 1 예
Isocyanate에 의한 과민성 폐렴 및 직업성 천식 동시 발생 1례
Positive PD-L1 expression is associated with unfavorable clinical outcome in EGFR-mutated lung adenocarcinomas treated with EGFR-TKIs
Deep vein thrombosis, pulmonary thromboembolism, aortic vegetation and stroke in advanced lung adenocarcinoma: A case of Trousseau’s syndrome
TAS-116, a Novel Heat Shock Protein 90 Inhibitor, Enhances Radiosensitivity of Lung Cancer Cells
Clinical Impact of Pulmonary Tuberculosis on the EGFR Mutational Status and Clinical Outcome in Patients with Lung Adenocarcinoma
Clinical Impact of Pulmonary Tuberculosis on the EGFR Mutational Status and Clinical Outcome in Patients with Lung Adenocarcinoma
A case of diffuse alveolar hemorrhage after illegal vaginal injection of hyaluronic acid
Total lymphocyte count and neutrophil-to-lymphocyte ratio as prognostic markers in patients with small cell lung cancer
전이성 폐선암 환자에서 pembrolizumab치료 중 발생한 근염 1 예
비디오 흉강경으로 진단된 급성 섬유소성 기질화 폐렴 1 예
A case of pulmonary sclerosing pneumocytoma with multiple lung and bone metastasis
경피적 바늘 폐생검 조직에서 폐선암과 폐결핵이 동시 진단된 1례
In-depth proteomic analysis of human bronchoalveolar lavage fluid towards the biomarker discovery for lung cancers
Radiosensitizing effect of combined triptolide and irradiation treatment in lung cancer cell lines
Positive PD-L1 expression is associated with unfavorable clinical outcome in EGFR-mutated lung adenocarcinomas treated with EGFR-TKIs
A case of pulmonary sclerosing pneumocytoma with multiple lung and bone metastasis
Isocyanate-induced hypersensitivity pneumonitis and coexistence of occupational asthma
Prolonged response to pembrolizumab in a patient with pulmonary sarcomatoid carcinoma
A case of mediastinal and pleural lipomatosis in a patient with seropositive rheumatoid arthritis
Unfavorable Outcome to Pembrolizumab in Lung Adenocarcinoma with High PD-L1 and STK11/KRAS co-mutations
Long-term efficacy of afatinib in lung adenocarcinoma harboring an EGFR exon 20 insertion
A Case of Desmoid Tumor Mimicking Pleural Recurrence after Curative Resection of Lung Adenocarcinoma
만성골수세포백혈병으로 다사티닙 복용 중 발생한 유미흉 1예
Triptolide enhances radiosensitivity of lung cancer cells via G2/M arrest and autophage
High PD-L1 expression is associated with unfavorable clinical outcome in EGFR-mutated lung adenocarcinomas treated with targeted therapy
A Case of Mediastinal and Pleural Lipomatosis in a Patient with Seropositive Rheumatoid Arthritis
Diagnostic and Predictive Values of 18F-FDG PET/ CT Metabolic Parameters in EGFR-Mutated Advanced Lung Adenocarcinoma
Primary Resistance to Immune Checkpoint Blockade in an STK11/TP53/KRAS-Mutant Lung Adenocarcinoma with High PD-L1 Expression